​

Spectral AI Stock (NASDAQ:MDAI)

RevenueOwnershipFinancialsChartTranscripts
Spectral AI by TradingView

Previous Close

$1.83

52W Range

$1.18 - $3.21

50D Avg

$2.02

200D Avg

$1.82

Market Cap

$59.19M

Avg Vol (3M)

$1.01M

Beta

1.15

Div Yield

-

MDAI Company Profile

Spectral AI, Inc. is an artificial intelligence (AI) firm specializing in AI-driven medical diagnostics. The company's primary goal is to facilitate faster and more accurate treatment decisions in wound care, particularly for patients dealing with burns and diabetic foot ulcers. Among its key products is DeepView, a predictive diagnostic device that delivers an objective and immediate evaluation of a wound's likely healing trajectory to clinicians, prior to any medical treatment or intervention. Spectral AI, Inc. is headquartered in Dallas, Texas.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

78

IPO Date

Apr 06, 2021

Website

MDAI Performance

MDAI Financial Summary

Dec 25Dec 24Dec 23
Revenue$19.65M$29.58M$18.06M
Operating Income$-8.60M$-6.58M$-12.98M
Net Income$-7.57M$-15.31M$-20.85M
EBITDA$-7.97M$-11.49M$-20.12M
Basic EPS$-0.29$-0.85$-1.48
Diluted EPS$-0.29$-0.85$-1.48

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 24, 26 | 12:00 AM
Q3 25Nov 11, 25 | 5:00 PM
Q2 25Aug 13, 25 | 5:00 PM

Peer Comparison

TickerCompany
COEPCoeptis Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
EQEquillium, Inc.
ICCMIceCure Medical Ltd
TELATELA Bio, Inc.
SRTSSensus Healthcare, Inc.
CTSOCytosorbents Corporation
TELOTelomir Pharmaceuticals, Inc. Common Stock
KPTIKaryopharm Therapeutics Inc.
ECORelectroCore, Inc.